JP Stock MarketDetailed Quotes

8260 Izutsuya

Watchlist

435
-1-0.23%

20min DelayMarket Closed Dec 17 15:30 JST

4.99BMarket Cap5.12P/E (Static)

Izutsuya Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Aug 31, 2024

(Q1)May 31, 2024

(FY)Feb 29, 2024

(Q4)Feb 29, 2024

(Q3)Nov 30, 2023

(Q2)Aug 31, 2023

(Q1)May 31, 2023

(FY)Feb 28, 2023

(Q4)Feb 28, 2023

(Q3)Nov 30, 2022

Total revenue

0.58%5.7B

-0.19%5.23B

-0.23%22.52B

-2.08%6.34B

6.93%5.28B

-1.29%5.67B

-3.41%5.24B

-57.52%22.57B

-56.35%6.48B

-62.65%4.93B

Cost of revenue

0.31%2.93B

1.53%2.52B

-0.35%11.21B

-5.19%3.25B

14.47%2.56B

-1.65%2.93B

-5.16%2.48B

-72.57%11.25B

-70.17%3.43B

-78.01%2.23B

Gross profit

0.91%2.77B

-1.74%2.71B

-0.11%11.31B

1.44%3.09B

0.70%2.72B

-0.94%2.74B

-1.75%2.76B

-6.66%11.32B

-8.85%3.05B

-11.70%2.7B

Operating expense

-0.47%2.55B

1.34%2.49B

1.65%10.31B

0.08%2.62B

0.41%2.67B

5.38%2.56B

0.94%2.46B

-8.79%10.14B

-7.53%2.61B

-6.86%2.66B

Staff costs

----

1.55%4.2B

----

-3.41%4.13B

----

Selling and administrative expenses

----

0.55%1.1B

----

-29.29%1.09B

----

-Selling and marketing expense

----

0.55%1.1B

----

-29.29%1.09B

----

Depreciation and amortization

----

3.06%1.45B

----

-11.86%1.4B

----

-Depreciation

----

3.06%1.45B

----

-11.86%1.4B

----

Rent and land expenses

----

-2.31%973M

----

0.10%996M

----

Other operating expenses

----

3.06%2.6B

----

-7.08%2.52B

----

Operating profit

20.79%215M

-27.00%219M

-15.16%1B

9.70%475M

19.51%49M

-46.87%178M

-19.35%300M

16.70%1.18B

-16.09%433M

-79.80%41M

Net non-operating interest income (expenses)

9.72%-65M

8.22%-67M

11.36%-281M

10.67%-67M

11.54%-69M

11.11%-72M

12.05%-73M

8.91%-317M

9.64%-75M

9.30%-78M

Non-operating interest income

--0

Non-operating interest expense

-9.72%65M

-8.22%67M

-11.36%281M

-10.67%67M

-11.54%69M

-11.11%72M

-12.05%73M

-8.91%317M

-9.64%75M

-9.30%78M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

-170M

-63.16%7M

135.29%40M

162.50%21M

111.11%19M

-84.68%17M

-60.00%8M

Special income (charges)

Other non-operating income (expenses)

-58.00%21M

-57.38%26M

-3.55%190M

63.27%80M

-101.75%-1M

117.39%50M

-10.29%61M

-28.62%197M

-27.94%49M

-21.92%57M

Income before tax

-99.36%1M

-39.22%186M

-11.91%947M

19.55%483M

-96.00%1M

-43.73%157M

-16.62%306M

3.27%1.08B

-18.55%404M

-88.04%25M

Income tax

-137.50%-3M

-66.67%-10M

-133.93%-19M

-118.63%-38M

0.00%17M

104.71%8M

-220.00%-6M

143.41%56M

285.45%204M

666.67%17M

Net income

-96.60%5M

-37.38%196M

-5.20%966M

161.00%522M

-300.00%-16M

-67.33%147M

-13.30%313M

-12.98%1.02B

-67.05%200M

-96.23%8M

Net income continuous operations

-97.32%4M

-37.18%196M

-5.20%966M

160.50%521M

-300.00%-16M

-66.82%149M

-13.81%312M

-12.91%1.02B

-67.00%200M

-96.23%8M

Noncontrolling interests

Net income attributable to the company

-96.60%5M

-37.38%196M

-5.20%966M

161.00%522M

-300.00%-16M

-67.33%147M

-13.30%313M

-12.98%1.02B

-67.05%200M

-96.23%8M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-96.60%5M

-37.38%196M

-5.20%966M

161.00%522M

-300.00%-16M

-67.33%147M

-13.30%313M

-12.98%1.02B

-67.05%200M

-96.23%8M

Gross dividend payment

Basic earnings per share

-96.75%0.42

-36.32%17.41

-4.47%84.97

164.29%45.96

-284.06%-1.27

-67.07%12.94

-13.40%27.34

-12.97%88.95

-67.13%17.39

-96.27%0.69

Diluted earnings per share

-96.73%0.42

-36.32%17.41

-4.47%84.97

164.29%45.96

-302.41%-1.3966

-67.33%12.8312

-13.40%27.34

-12.97%88.95

-67.13%17.39

-96.27%0.69

Dividend per share

0.00%5

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Aug 31, 2024	(Q1)May 31, 2024	(FY)Feb 29, 2024	(Q4)Feb 29, 2024	(Q3)Nov 30, 2023	(Q2)Aug 31, 2023	(Q1)May 31, 2023	(FY)Feb 28, 2023	(Q4)Feb 28, 2023	(Q3)Nov 30, 2022
Total revenue	0.58%5.7B	-0.19%5.23B	-0.23%22.52B	-2.08%6.34B	6.93%5.28B	-1.29%5.67B	-3.41%5.24B	-57.52%22.57B	-56.35%6.48B	-62.65%4.93B
Cost of revenue	0.31%2.93B	1.53%2.52B	-0.35%11.21B	-5.19%3.25B	14.47%2.56B	-1.65%2.93B	-5.16%2.48B	-72.57%11.25B	-70.17%3.43B	-78.01%2.23B
Gross profit	0.91%2.77B	-1.74%2.71B	-0.11%11.31B	1.44%3.09B	0.70%2.72B	-0.94%2.74B	-1.75%2.76B	-6.66%11.32B	-8.85%3.05B	-11.70%2.7B
Operating expense	-0.47%2.55B	1.34%2.49B	1.65%10.31B	0.08%2.62B	0.41%2.67B	5.38%2.56B	0.94%2.46B	-8.79%10.14B	-7.53%2.61B	-6.86%2.66B
Staff costs	----	----	1.55%4.2B	----	----	----	----	-3.41%4.13B	----	----
Selling and administrative expenses	----	----	0.55%1.1B	----	----	----	----	-29.29%1.09B	----	----
-Selling and marketing expense	----	----	0.55%1.1B	----	----	----	----	-29.29%1.09B	----	----
Depreciation and amortization	----	----	3.06%1.45B	----	----	----	----	-11.86%1.4B	----	----
-Depreciation	----	----	3.06%1.45B	----	----	----	----	-11.86%1.4B	----	----
Rent and land expenses	----	----	-2.31%973M	----	----	----	----	0.10%996M	----	----
Other operating expenses	----	----	3.06%2.6B	----	----	----	----	-7.08%2.52B	----	----
Operating profit	20.79%215M	-27.00%219M	-15.16%1B	9.70%475M	19.51%49M	-46.87%178M	-19.35%300M	16.70%1.18B	-16.09%433M	-79.80%41M
Net non-operating interest income (expenses)	9.72%-65M	8.22%-67M	11.36%-281M	10.67%-67M	11.54%-69M	11.11%-72M	12.05%-73M	8.91%-317M	9.64%-75M	9.30%-78M
Non-operating interest income	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Non-operating interest expense	-9.72%65M	-8.22%67M	-11.36%281M	-10.67%67M	-11.54%69M	-11.11%72M	-12.05%73M	-8.91%317M	-9.64%75M	-9.30%78M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests	-170M	-63.16%7M	135.29%40M	0	162.50%21M	0	111.11%19M	-84.68%17M	0	-60.00%8M
Special income (charges)
Other non-operating income (expenses)	-58.00%21M	-57.38%26M	-3.55%190M	63.27%80M	-101.75%-1M	117.39%50M	-10.29%61M	-28.62%197M	-27.94%49M	-21.92%57M
Income before tax	-99.36%1M	-39.22%186M	-11.91%947M	19.55%483M	-96.00%1M	-43.73%157M	-16.62%306M	3.27%1.08B	-18.55%404M	-88.04%25M
Income tax	-137.50%-3M	-66.67%-10M	-133.93%-19M	-118.63%-38M	0.00%17M	104.71%8M	-220.00%-6M	143.41%56M	285.45%204M	666.67%17M
Net income	-96.60%5M	-37.38%196M	-5.20%966M	161.00%522M	-300.00%-16M	-67.33%147M	-13.30%313M	-12.98%1.02B	-67.05%200M	-96.23%8M
Net income continuous operations	-97.32%4M	-37.18%196M	-5.20%966M	160.50%521M	-300.00%-16M	-66.82%149M	-13.81%312M	-12.91%1.02B	-67.00%200M	-96.23%8M
Noncontrolling interests
Net income attributable to the company	-96.60%5M	-37.38%196M	-5.20%966M	161.00%522M	-300.00%-16M	-67.33%147M	-13.30%313M	-12.98%1.02B	-67.05%200M	-96.23%8M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-96.60%5M	-37.38%196M	-5.20%966M	161.00%522M	-300.00%-16M	-67.33%147M	-13.30%313M	-12.98%1.02B	-67.05%200M	-96.23%8M
Gross dividend payment
Basic earnings per share	-96.75%0.42	-36.32%17.41	-4.47%84.97	164.29%45.96	-284.06%-1.27	-67.07%12.94	-13.40%27.34	-12.97%88.95	-67.13%17.39	-96.27%0.69
Diluted earnings per share	-96.73%0.42	-36.32%17.41	-4.47%84.97	164.29%45.96	-302.41%-1.3966	-67.33%12.8312	-13.40%27.34	-12.97%88.95	-67.13%17.39	-96.27%0.69
Dividend per share	0	0	0.00%5	0.00%5	0	0	0	0.00%5	0.00%5	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Top JP Stock Gainers

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.